tiprankstipranks
Trending News
More News >
Vincerx Pharma Inc (VINC)
NASDAQ:VINC
US Market

Vincerx Pharma Inc (VINC) Income Statement

Compare
266 Followers

Vincerx Pharma Inc Income Statement

Last quarter (Q3 2024), Vincerx Pharma Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Vincerx Pharma Inc's net income was $-7.84M. See Vincerx Pharma Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -915.00K$ -939.00K$ -340.00K$ -173.00K
Operating Expenses
$ 31.46M$ 42.61M$ 71.11M$ 62.66M$ 10.71M
Depreciation and Amortization
$ 0.00$ 52.00K$ 939.00K$ 340.00K$ 5.71M
EBITDA
$ -31.46M$ -42.61M$ -68.67M$ -62.66M$ -10.71M
Operating Income
$ -31.46M$ -42.61M$ -73.57M$ -62.66M$ -10.71M
Other Income/Expenses
$ 1.39M$ 2.45M$ 8.21M$ 23.35M$ -5.91M
Pretax Income
$ -30.07M$ -40.16M$ -65.37M$ -39.31M$ -10.72M
Net Income
$ -30.07M$ -40.16M$ -57.16M$ -15.61M$ -10.73M
Per Share Metrics
Basic EPS
$ -15.85$ -1.89$ -2.72$ -0.91$ -0.77
Diluted EPS
$ -15.85$ -1.89$ -2.72$ -0.91$ -0.77
Weighted Average Shares Outstanding
1.90M 21.30M 21.03M 17.18M 13.98M
Weighted Average Shares Outstanding (Diluted)
1.90M 21.30M 21.03M 17.18M 13.98M
Currency in USD

Vincerx Pharma Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis